A new study led by researchers at the University of Cambridge has revealed that damage to the brain’s white matter can act as a catalyst for neurodegenerative-like changes, including inflammation in the grey matter. While conditions like Alzheimer’s and Parkinson’s disease have traditionally been associated with grey matter changes, these findings published in the journal Nature highlight the critical, often overlooked role of white matter integrity in brain health.
The researchers focused on myelin, the protective coating of the brain’s white matter, which acts as an “information highway” for processing hubs. By creating localized damage to myelin, the team observed a coordinated response in connected, remote grey matter regions, where neuronal activity declined, brain immune cells (microglia) became activated, and neuronal connections were lost. This process is initially part of the brain’s attempt to repair itself, but the study discovered that when myelin regeneration fails, this helpful response can turn into the chronic, low-grade inflammation characteristic of neurodegenerative diseases.
These findings suggest a shift in medical strategy, indicating that treatments for neurodegenerative conditions should target white matter damage alongside grey matter pathology. Professor Alasdair Coles from the University of Cambridge noted that therapies designed to enhance myelin regeneration could hold significant potential for slowing the progression of a wide range of brain disorders.
